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MarchiafavaeBignami disease is a rare toxic encephalopathy seen mostly in chronic al-
coholics due to progressive demyelination and necrosis of the corpus callosum. It may
involve adjacent white matter and subcortical regions. We present here the magnetic
resonance imaging findings of MachiafavaeBignami disease in a chronic alcoholic patient.
In 1903, Italian pathologists Marchiafava and Bignami described 3 alcoholic men who died
after having seizures and coma. All 3 patients were chronic alcoholics and had consumed
considerable amounts of red wine.
© 2016 the Author. Published by Elsevier Inc. under copyright license from the University of
Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).History
A 45-year-old chronic alcoholic patient who was taking
alcohol for 20 years and presentedwith altered sensorium and
seizures.
Patient’s family reported that he had consumed a daily
average of 250 mL of liquor for 2 weeks. The patient was in
poor physical condition and seemed malnourished. The pa-
tient is diagnosed case of liver cirrhosis since 5 years. On ex-
amination, the patient was confused. Although there was no
weakness in his extremities, he demonstrated lack of motor
coordination. Electroencephalogram showed diffuse slow
waves of 5-8 Hz without epileptiform discharge.
Laboratory test results revealedhyperosmosisof370mmol/L
(normal, 290mmol/L), highblood creatinine (2.1mg/dL; normal,
0.5-1.2 mg/dL), and high blood urea nitrogen (40.0 mg/dL;
normal, 8-23 mg/dL). Sodium and potassium levels were,
respectively, 146 mmol/L and 4.3 mmol/L. Cerebrospinal fluid
studies revealednoabnormalities. Thereare lowserumlevelsof
vitamin B12, folic acid, and albumin seen.Elsevier Inc. under copyr
se (http://creativecommoImaging findings
Cranial computed tomography showed diffuse corpus callosal
and bilateral periventricular hypodensity.Protocol
Magnetic resonance imaging (MRI) was performed on a 1.5 T
magnet (GE Signa, 1.5 T, General Electric). Fast spin-echo
T1-weighted (repetition time [TR]: 650ms, echo time [TE]:
14ms), T2-weighted (dual-echo TR, 2014ms; TE, 30 and 100ms),
andfluid attenuation and inversion recovery (FLAIR; TurboSpin
Echo; turbo factor 11; TR, 5496 ms; TE, 100 ms; inversion time,
2000 ms) images in axial and sagittal planes were acquired.
Diffusion-weighted imaging (DWI) scans were acquired with
diffusion gradients along each of the 3 principal axes with 3
different values (0, 187, and 757 s/mm2). Postcontrast
T1-weighted (TR, 650ms; TE, 14ms) imageswere acquired after
intravenous administration of 0.2 mL/kg body weight ofight license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e In a 45-year-old chronic alcoholic patient presented with seizures, altered sensorium, and bilateral lower limb
paresis, T1W (upper row right) image shows hypointense corpus callosum and periventricular white matter with
corresponding T2 (upper row left and middle row) and FLAIR (lower row right images shows hyperintense signal with true
restricted diffusion in DWI image (lower row left). There is no postcontrast enhancement seen (last image).
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 2 3 4e2 3 7 235gadodiamide (Omniscan) at a rate of 4 mL/s with a delay of 10
minutes in the axial and sagittal planes.
Figure 1 shows on T2-weighted and FLAIR images show
diffuse hyperintensity in corpus callosum and bilateral per-
iventricular white matter with corresponding T1-
hypointense signal. On DWI images restricted diffusion
seen in bilateral peritrigonal white matter and middle layer
of splenium of corpus callosum with corresponding drop in
signal on apparent diffusion coefficient seen. There is no
evidence of increased abnormal signal in the subcortical
white matter seen. There is no evidence of postcontrast
enhancement.
MarchiafavaeBignami disease (MBD) was diagnosed based
on the clinical and imaging features.Discussion
MBD is a rare complication of chronic alcoholism character-
ized by demyelinization and necrosis of the entire length and
middle layer of corpus callosum with extension into hemi-
spheric white matter [1,2]. Occasionally, other structures of
the central nervous systemmay be involved, such as the optic
chiasm and tracts, putamen, cerebellar peduncle, and anteriorcommissure. Cortical gray matter and subcortical U fibers are
involved rarely [3,4].
Most accepted etiologic factor is the in multiple vitamin B
deficiency [5].
Clinical manifestations [6]:
(1) Acute state: seizures, alterations of consciousness, and
death may occur.
(2) Subacute state: characterized by mental confusion,
behavioral disorders, memory deficits, cerebellar signs,
and interhemispheric disconnection.
(3) Chronic state: mild dementia.
Clinicoradiological subtypes of MBD [6,7]:
(1) Type A: characterized by alterations of consciousness
and diffuse swelling of the entire corpus callosum on
imaging.
(2) Type B: mild impairment of consciousness and small
callosal lesions associated with good prognosis.
On MRI images [8], T1W shows confluent hypointense
signal intensity of corpus callosum.
T2 and FLAIR shows hyperintense signal in middle layer of
corpus callosum (Sandwich sign).
Fig. 1 e (continued).
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DWI, in the acute phase, shows restricted diffusion
because of cytotoxic edema caused by increase of extracel-
lular glutamate that binds NMDA (N-methyl-D-aspartic acid)
receptors inducing calcium entry and finally apoptosis
without brain ischemia.
Apparent diffusion coefficient was the low apparent
diffusion coefficient.
Early diagnosis and treatment can improve clinical
outcome. MRI findings can help to differentiate MBD from
other corpus callosal lesions and also from alcohol-related
disorders.
MBD is commonly associated with other manifestations of
chronic alcohol abuse such as
(1 )Wernicke's encephalopathy,
(2) Central pontine myelinolysis, and
(3) Morel's laminar sclerosis.
The genu is usually themost involved structure followedby
the splenium. The entire corpus callosum may also be
involved. Incaseof chronicstage, corpuscallosumdegenerates
and separates into 3 layers with necrotic cavitiesmainly in themiddle layer. Cortical involvement is extremely rare andwhen
present, it is usually localized in lateral-frontal regions. [2]
In conclusion, even if it is not possible to identify patho-
gnomonic characteristics of MBD lesions, the clinical aspects
and neuroimaging pattern may helpful for the diagnosis.Treatment
No specific, proven treatment is available for MBD. Various
treatments similar to those commonly administered for
WernickeeKorsakoff syndrome or for alcoholism in general
have been given to patients with MBD.
Vitamins
Themost commonly given treatments are B complex vitamins
including thiamine, folate, and other B vitamins (especially
vitamin B-12). Folate is commonly given with B-12.
Because thiamine deficiency is associated with malnutri-
tion and prolonged vomiting in alcoholics, MBD patients with
these symptoms may effective from parenteral thiamine
administered within 15 days of symptom onset. [9]
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With regard to more unusual treatments, a case report by
Staszewski et al [10] described amantadine given together
with thiamine, vitamin B-12, and folate, the patient
improved.Immunosuppressant therapy
In another case, reported by Kikkawa et al [11], administration
of high-dose corticosteroids was said to precede clinical
improvement. In patients who improved, the computed to-
mography and MRI scan findings also improved, at least
somewhat.
Patients are usually admitted because they present with
stupor, coma, and, frequently, seizures.
Patients who survive should receive rehabilitation and, if
appropriate, alcohol and nutritional counseling.
In our patient was given high-dose vitamin B complex,
injectable optineuron including 500 mg/d thiamine intrave-
nously for 10-15 days. Patient showed gradual clinical
improvement.Differential diagnosis
To differentiate MBD lesions to other possible causes of cal-
losal damage, we have to consider their specific localization
inside the corpus callosum.
Wernicke's encephalopathy is characterized by lesions
involving midline structures such as medial thalami,
hypothalami, mammillary bodies, and periaqueductal gray
matter. In a few cases of Wernicke's encephalopathy,
cortical abnormalities are unusually restricted to themotor
and premotor cortices. [12] Our patient's MR images
revealed symmetrical hyperintensity in the bilateral peri-
ventricular areas. At the same time, our patient did not
present ophthalmoplegia, nystagmus, or ataxia and did not
show MR findings typical of Wernicke's encephalopathy,
such as symmetrical hyperintense lesions surrounding the
third ventricle and aqueduct.
Other differentialsCorpus callosum glioma: Produces enlargement of the
corpus callosum with mass effect.
Demyelination: lesions are usually discrete and shows
perpendicular arrangement called Dawson’s fingers.Vascular lesions: lesions are usually more discrete in
distribution.
Final diagnosis: MBD type A in chronic phase.Teaching point
MBD seen in chronic alcoholic patient is due to B complex
deficiency On neuroimaging, it shows corpus callosal and
periventricular white matter involvement.r e f e r e n c e s
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